Back to results
US 10,329,270 B2Granted
Heteroaryl compounds as BTK inhibitors and uses thereof
AssigneeMerck Patent GmbH
InventorsHui Qiu, Richard D. Caldwell, Constantin Neagu, Igor Mochalkin, Lesley Liu-Bujalski, Reinaldo Jones, Devon Tate, Theresa L. Johnson, Anna Gardberg
Life of this patent
Estimating the term…
Abstract
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
Claims3
A compound selected from the group consisting of
- and
- a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.